Cargando…
(99m)Tc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types
ABSTRACT: The expression status of human epidermal growth factor receptor 2 (HER2) in cancer predicts response to HER2-targeted therapy. Therefore, its accurate determination is of utmost importance. In recent years, there has been an increase in research on noninvasive techniques for molecular imag...
Autores principales: | Altunay, Betül, Goedicke, Andreas, Winz, Oliver H., Hertel, Fabian, von Mallek, Dirk, Meszaros, Levente K., Chand, Gitasha, Biersack, Hans-Jürgen, Stickeler, Elmar, Krauss, Katja, Mottaghy, Felix M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931776/ https://www.ncbi.nlm.nih.gov/pubmed/36482076 http://dx.doi.org/10.1007/s00259-022-06066-3 |
Ejemplares similares
-
Comparison of [(99m)Tc]Tc-tilmanocept with [(99m)Tc]Tc-sulphur colloids and [(99m)Tc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head
por: Ooms, Mark, et al.
Publicado: (2022) -
HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
por: Altunay, Betül, et al.
Publicado: (2020) -
SPECT/CT imaging of chemotherapy-induced tumor apoptosis using (99m)Tc-labeled dendrimer-entrapped gold nanoparticles
por: Xing, Yan, et al.
Publicado: (2018) -
Early Phase I Study of a (99m)Tc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer
por: Xing, Yan, et al.
Publicado: (2019) -
RETRACTED ARTICLE: Inter- and intraobserver agreement of the quantitative assessment of [(99m)Tc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer
por: Hughes, Daniel Johnathan, et al.
Publicado: (2020)